BARDA Awards $51.9 Million Contract to DNAe to Develop Semiconductor DNA Sequencing Platform for Rapid Diagnosis of Antimicrobial Resistant Infections and Influenza

News The contract will support testing and FDA clearance of the sequencing platform for a series of applications. The initial focus will address two of the most significant threats to global health: Antimicrobial resistance and influenza. Contributed Author:  DNA Electronics Topics:  Medical Diagnostics